Cumberland Pharmaceuticals Inc. CPIX

7.61 (0.40) (4.99%) as of 25 Sep
Market cap
$120.0M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
50.13 50.09 36.23 28.21 24.75 27.04 19.76 18.32 17.96 11.44
Receivables
7.33 8.40 7.84 7.86 12.38 6.88 13.16 9.76 11.70 16.94
Inventory
5.37 6.74 12.08 8.87 10.64 8.43 9.86 4.61 4.00 6.23
Total current assets
65.55 68.68 59.12 50.16 49.97 45.69 45.87 35.71 36.45 37.06
Property, Plant, Equpment (Net)
0.46 0.53 0.77 0.75 0.57 0.44 0.28 0.37 0.28 0.26
Long-Term Investments
— — — — — — — — — 3.99
Goodwill and Intangible Assets (Total)
22.15 21.44 34.44 31.80 29.00 24.84 31.50 23.52 18.89 14.94
Long Term Assets (Tax, Deferred)
3.12 0.09 0.09 0.02 — — — — — —
Long-term assets (Other)
2.12 2.49 2.53 3.30 3.23 3.42 2.52 2.69 2.78 2.97
Total non-current assets
27.86 24.55 53.58 54.39 46.49 38.77 47.06 46.06 39.13 39.76
Total Assets
93.40 93.23 112.69 104.55 96.46 84.46 92.93 81.78 75.58 76.82
Accounts Payable
8.04 8.98 11.09 9.99 13.40 9.64 10.82 14.04 13.91 18.57
Current Part of Debt
— — — 0.92 1.02 0.97 0.17 — 5.10 —
Other current liabilities
6.76 8.71 16.71 11.08 11.25 8.67 17.59 13.60 12.25 17.71
Total current liabilities
14.79 17.69 27.80 24.15 25.67 19.28 28.58 27.98 31.62 36.74
Long Term Debt (Total)
4.10 9.80 20.00 18.50 15.00 15.00 16.20 12.78 10.18 5.24
Non-current Liabilities (Other)
1.39 1.82 9.32 8.74 7.86 7.49 7.59 6.45 6.30 5.82
Total non-current liabilities
5.49 11.62 29.32 29.31 23.92 22.58 28.37 24.53 21.42 15.53
Total liabilities
20.28 29.31 57.12 53.46 49.59 41.86 56.95 52.52 53.04 52.28
Common Stock (Net)
54.64 52.41 51.10 49.91 49.12 48.45 47.48 47.09 46.82 51.68
Retained Earnings
18.60 11.71 4.75 1.21 (2.13) (5.64) (11.21) (17.49) (23.97) (26.80)
Common Equity (Total)
73.12 63.92 55.57 51.09 46.87 42.60 35.97 29.26 22.55 24.54
Shareholders Equity (Total)
73.12 63.92 55.57 51.09 46.87 42.60 35.97 29.26 22.55 24.54
Shareholders Equity and Liabilities (Total)
93.40 93.23 112.69 104.55 96.46 84.46 92.93 81.78 75.58 76.82
Shares (Common)
16.07 15.72 15.48 15.26 14.99 14.74 14.37 14.12 13.95 14.96
Shareholders Equity (Tangible)
50.97 42.48 21.13 19.28 17.87 17.77 4.47 5.74 3.66 9.60
Net Debt
(46.03) (40.29) (16.23) (8.79) (8.74) (11.07) (3.39) (5.54) (2.69) (6.20)
Total Debt
4.10 9.80 20.00 19.42 16.02 15.97 16.37 12.78 15.28 5.24

Fold the line items

In millions of $ except per-share values · columns are period end dates